Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-015612
Filing Date
2025-04-25
Accepted
2025-04-25 09:01:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20041194x2_defa14a.htm DEFA14A 15417
2 ny20041194x2_nc01.jpg GRAPHIC 384496
3 ny20041194x2_nc02.jpg GRAPHIC 198412
  Complete submission text file 0001140361-25-015612.txt   819612
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39539 | Film No.: 25870191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)